Vera TherapeuticsVERA

那斯達克 · USD
34.57
-0.71
(-2.01%)
盤中 09/10 12:50 (UTC+8)
09/10 12:50 (UTC+8)

財務數據

損益表

loading
載入中...
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
icon
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • -
  • icon
    營業收入(億)
  • icon
    季增長率(%)
單位:美元千元
年季
2026/Q2
2026/Q1
2025/Q4
2025/Q3
2025/Q2
2025/Q1
2024/Q4
2024/Q3
2024/Q2
2024/Q1
營業收入淨額
-
-
-
-
-
-
-
-
-
-
營業成本
----------
營業毛利
-
-
-
-
-
-
-
-
-
-
營業費用
112,490125,13294,20683,93280,14157,19448,91449,80137,343-
研發費用
60,08086,01159,31056,47358,19541,27833,34740,31429,31123,200
推銷及管理費用
52,41039,12134,89627,45921,94615,91615,5679,4878,0327,912
非經常性項目費用
----------
其他營業費用
----------
營業利益
-112,490
-125,132
-94,206
-83,932
-80,141
-57,194
-48,914
-49,801
-37,343
-31,112
其他收入及費用
4,8655,9235,0145,599-7,2927,3615,1055,5484,635
利息費用
1,8481,8231,9041,9601,8741,7921,8711,9361,9131,906
稅前純益
-109,473
-121,032
-91,096
-80,293
-76,531
-51,694
-43,424
-46,632
-33,708
-28,383
所得稅
--1---1---
稅後純益
-109,473
-121,032
-91,097
-80,293
-76,531
-51,694
-43,425
-46,632
-33,708
-28,383
基本每股稅後盈餘(元)
-1.52-1.69-1.39-1.26-1.20-0.81-0.72-0.85-0.62-0.56
稀釋每股稅後盈餘(元)
-1.53-1.69-1.39-1.26-1.20-0.81-0.72-0.86-0.61-0.56
基本平均股數(千股)
71838.0071476.0065628.0063847.0063789.0063671.0060709.0054898.0054728.0050971.00
稀釋平均股數(千股)
71838.0071476.0065628.0063847.0063789.0063671.0060709.0054898.0054728.0050971.00
還原基本每股稅後盈餘(元)
-1.52-1.69-1.39-1.26-1.20-0.81-0.72-0.85-0.62-0.56
還原稀釋每股稅後盈餘(元)
-1.53-1.69-1.39-1.26-1.20-0.81-0.72-0.86-0.61-0.56
還原基本平均股數(千股)
71,83871,47665,62863,84763,78963,67160,70954,89854,72850,971
還原稀釋平均股數(千股)
71,83871,47665,62863,84763,78963,67160,70954,89854,72850,971
EBITDA(千元)
-107,945-119,273-89,529-78,812-74,538-52,127-43,347-46,896-34,389-27,946

大家都在看

HOT